These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions. Khedraki R Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939 [TBL] [Abstract][Full Text] [Related]
11. Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin to creatinine ratio and need for further evidence generation. Khan MS; Sperry BW; Butler J Eur J Heart Fail; 2024 Jan; 26(1):74-76. PubMed ID: 38191996 [No Abstract] [Full Text] [Related]
12. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. Mohammed SF; Mirzoyev SA; Edwards WD; Dogan A; Grogan DR; Dunlay SM; Roger VL; Gertz MA; Dispenzieri A; Zeldenrust SR; Redfield MM JACC Heart Fail; 2014 Apr; 2(2):113-22. PubMed ID: 24720917 [TBL] [Abstract][Full Text] [Related]
13. Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis. Sperry BW; Jones BM; Vranian MN; Hanna M; Jaber WA JACC Cardiovasc Imaging; 2016 Jul; 9(7):904-906. PubMed ID: 27085437 [No Abstract] [Full Text] [Related]